The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is being created with $4 million in matching funds from the National Institutes of Health.
NIH-funded, nationwide study, led by a UW Medicine newborn care physician, suggests erythropoietin, while safe, may not protect against severe brain damage.
